Note 3 - Intangible Assets, Net

9 Months Ended

Mar. 31, 2016

Intangible Assets Disclosure [Text Block]

Note 3. Intangible Assets, net

Intangible assets consist of trade names, license fees from the Branded Proprietary Products Segment, and unpatented technology from the Other Nutraceutical Businesses Segment. The carrying amount of intangible assets, net is as follows as of:

	March 31, 2016						June 30, 2015
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net

Trade names	$	1,525	$	948	$	577	$	1,525	$	891	$	634
Unpatented technology		547		547		-		547		540		7
License agreement		347		261		86		347		245		102
Total	$	2,419	$	1,756	$	663	$	2,419	$	1,676	$	743

Amortization expense recorded on intangible assets for three and nine months ended March 31, 2016 and 2015 was $25 and $80 and $34 and $103, respectively. Amortization expense is recorded on the straight-line basis over periods ranging from 13 years to 20 years based on contractual or estimated lives and is included in selling and administrative expenses. Tests for impairment or recoverability are performed at least annually and require significant management judgment and the use of estimates which the Company believes are reasonable and appropriate at the time of the impairment test. Future unanticipated events affecting cash flows and changes in market conditions could affect such estimates and result in the need for an impairment charge. The Company also re-evaluates the periods of amortization to determine whether circumstances warrant revised estimates of current useful lives. No impairment losses were identified or recorded in the three and nine months ended March 31, 2016 and 2015 on the Company’s intangible assets.

The estimated annual amortization expense for intangible assets for the five succeeding fiscal years is as follows:

Year ending June 30,	Amortization Expense

Remaining in 2016	$	24
2017		97
2018		97
2019		97
2020		93
2021		76
Thereafter		179
Total	$	663